These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34938086)

  • 21. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
    Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
    J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
    Satlin MJ; Cohen N; Ma KC; Gedrimaite Z; Soave R; Askin G; Chen L; Kreiswirth BN; Walsh TJ; Seo SK
    J Infect; 2016 Oct; 73(4):336-45. PubMed ID: 27404978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections.
    White BP; Patel S; Tsui J; Chastain DB
    Infect Dis (Lond); 2019 Mar; 51(3):161-167. PubMed ID: 30663923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Epidemiology and Risk Factors of Ventilator-Associated Pneumonia Infection Caused by Carbapenem-Resistant Enterobacteriaceae.
    Gao B; Li X; Yang F; Chen W; Zhao Y; Bai G; Zhang Z
    Front Pharmacol; 2019; 10():262. PubMed ID: 30967778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to
    Martin A; Fahrbach K; Zhao Q; Lodise T
    Open Forum Infect Dis; 2018 Jul; 5(7):ofy150. PubMed ID: 30046639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
    Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M
    Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by
    Zhen X; Stålsby Lundborg C; Sun X; Gu S; Dong H
    Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32823707
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    Ara-Montojo MF; Escosa-García L; Alguacil-Guillén M; Seara N; Zozaya C; Plaza D; Schuffelmann-Gutiérrez C; de la Vega Á; Fernández-Camblor C; Ramos-Boluda E; Romero-Gómez MP; Ruiz-Carrascoso G; Losantos-García I; Mellado-Peña MJ; Gómez-Gil R
    J Antimicrob Chemother; 2021 Jan; 76(1):220-225. PubMed ID: 33038895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better?
    Yang TT; Luo XP; Yang Q; Chen HC; Luo Y; Zhao YM; Ye YS; Lai XY; Yu J; Tan YM; Wei GQ; Huang H; Shi JM
    Antimicrob Resist Infect Control; 2020 Mar; 9(1):49. PubMed ID: 32183898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of a Risk Prediction Model for Subsequent Bloodstream Infection in Intestinal Carriers of Carbapenem-Resistant Enterobacteriaceae: A Retrospective Study in Hematology Department and Intensive Care Unit.
    Wang Y; Lin Q; Chen Z; Hou H; Shen N; Wang Z; Wang F; Sun Z
    Infect Drug Resist; 2021; 14():815-824. PubMed ID: 33688216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study.
    Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
    Antimicrob Resist Infect Control; 2017; 6():124. PubMed ID: 29225798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of disease.
    Tran DM; Larsson M; Olson L; Hoang NTB; Le NK; Khu DTK; Nguyen HD; Vu TV; Trinh TH; Le TQ; Phan PTT; Nguyen BG; Pham NH; Mai BH; Nguyen TV; Nguyen PTK; Le ND; Huynh TM; Anh Thu LT; Thanh TC; Berglund B; Nilsson LE; Bornefall E; Song LH; Hanberger H
    J Infect; 2019 Aug; 79(2):115-122. PubMed ID: 31125639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA).
    Pérez-Galera S; Bravo-Ferrer JM; Paniagua M; Kostyanev T; de Kraker MEA; Feifel J; Sojo-Dorado J; Schotsman J; Cantón R; Daikos GL; Carevic B; Dragovac G; Tan LK; Raka L; Hristea A; Viale P; Akova M; Reguera JM; Valiente de Santis L; Torre-Cisneros J; Cano Á; Roilides E; Radulovic L; Kirakli C; Shaw E; Falagas ME; Pintado V; Goossens H; Bonten MJ; Gutiérrez-Gutiérrez B; Rodriguez-Baño J;
    EClinicalMedicine; 2023 Mar; 57():101871. PubMed ID: 36895801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.
    Bartsch SM; McKinnell JA; Mueller LE; Miller LG; Gohil SK; Huang SS; Lee BY
    Clin Microbiol Infect; 2017 Jan; 23(1):48.e9-48.e16. PubMed ID: 27642178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae.
    Luo H; Xiao Y; Hang Y; Chen Y; Zhu H; Fang X; Cao X; Zou S; Hu X; Xiong J; Zhong Q; Hu L
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):63. PubMed ID: 34488786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial Resistance or Delayed Appropriate Therapy-Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
    Lodise TP; Berger A; Altincatal A; Wang R; Bhagnani T; Gillard P; Bonine NG
    Open Forum Infect Dis; 2019 Jun; 6(6):ofz194. PubMed ID: 31198817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.